CN101890152B - 山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 - Google Patents
山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 Download PDFInfo
- Publication number
- CN101890152B CN101890152B CN 201010171533 CN201010171533A CN101890152B CN 101890152 B CN101890152 B CN 101890152B CN 201010171533 CN201010171533 CN 201010171533 CN 201010171533 A CN201010171533 A CN 201010171533A CN 101890152 B CN101890152 B CN 101890152B
- Authority
- CN
- China
- Prior art keywords
- glucoprotein
- brown
- chinese potato
- chinese yam
- potato glucoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000002722 Dioscorea batatas Nutrition 0.000 title claims abstract description 45
- 239000003814 drug Substances 0.000 title claims abstract description 15
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 7
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 102000003886 Glycoproteins Human genes 0.000 title abstract description 4
- 108090000288 Glycoproteins Proteins 0.000 title abstract description 4
- 235000006536 Dioscorea esculenta Nutrition 0.000 title abstract 7
- 240000001811 Dioscorea oppositifolia Species 0.000 title abstract 7
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 title abstract 7
- 230000000141 anti-hypoxic effect Effects 0.000 title abstract 3
- 241000234272 Dioscoreaceae Species 0.000 claims abstract description 11
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims abstract description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000007787 solid Substances 0.000 claims abstract description 7
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 6
- 150000004676 glycans Chemical class 0.000 claims abstract description 5
- 239000004475 Arginine Substances 0.000 claims abstract description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 4
- 239000004471 Glycine Substances 0.000 claims abstract description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000004472 Lysine Substances 0.000 claims abstract description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims abstract description 4
- 229940024606 amino acid Drugs 0.000 claims abstract description 4
- 150000001413 amino acids Chemical class 0.000 claims abstract description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 4
- 229930182830 galactose Natural products 0.000 claims abstract description 4
- 239000008103 glucose Substances 0.000 claims abstract description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960000310 isoleucine Drugs 0.000 claims abstract description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000004474 valine Substances 0.000 claims abstract description 4
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 claims description 43
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- 235000005602 Coleus parviflorus Nutrition 0.000 claims description 38
- 206010021143 Hypoxia Diseases 0.000 claims description 16
- 239000006228 supernatant Substances 0.000 claims description 15
- 229920000297 Rayon Polymers 0.000 claims description 11
- 239000003292 glue Substances 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000000151 deposition Methods 0.000 claims description 7
- 230000008021 deposition Effects 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 102000011759 adducin Human genes 0.000 claims description 5
- 108010076723 adducin Proteins 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- 241001529246 Platymiscium Species 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- 229930091371 Fructose Natural products 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 150000004804 polysaccharides Polymers 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- -1 lysine Chemical class 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- 235000006109 methionine Nutrition 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 238000000247 postprecipitation Methods 0.000 claims description 2
- 235000013930 proline Nutrition 0.000 claims description 2
- 235000018102 proteins Nutrition 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 235000004400 serine Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 235000008521 threonine Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 238000002474 experimental method Methods 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract description 2
- 229920001282 polysaccharide Polymers 0.000 abstract description 2
- 239000005017 polysaccharide Substances 0.000 abstract description 2
- 230000017854 proteolysis Effects 0.000 abstract description 2
- 241000234273 Dioscorea Species 0.000 abstract 1
- 235000005903 Dioscorea Nutrition 0.000 abstract 1
- 235000000504 Dioscorea villosa Nutrition 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 229920000715 Mucilage Polymers 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 229940009098 aspartate Drugs 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 229960002737 fructose Drugs 0.000 abstract 1
- 206010002660 Anoxia Diseases 0.000 description 9
- 241000976983 Anoxia Species 0.000 description 8
- 230000007953 anoxia Effects 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010171533 CN101890152B (zh) | 2010-05-13 | 2010-05-13 | 山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010171533 CN101890152B (zh) | 2010-05-13 | 2010-05-13 | 山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101890152A CN101890152A (zh) | 2010-11-24 |
CN101890152B true CN101890152B (zh) | 2012-12-05 |
Family
ID=43099610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010171533 Expired - Fee Related CN101890152B (zh) | 2010-05-13 | 2010-05-13 | 山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101890152B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102920991B (zh) * | 2012-12-05 | 2014-05-07 | 多力坤·马木特 | 山药多糖和山药蛋白质的组合物的用途 |
CN102920999B (zh) * | 2012-12-05 | 2013-10-30 | 多力坤·马木特 | 山药糖蛋白在制备治疗肾炎及肾性高血压的药物中的用途 |
CN102920998B (zh) * | 2012-12-05 | 2013-12-25 | 多力坤·马木特 | 山药糖蛋白在提高脑细胞线粒体氧化代谢酶活性的用途 |
CN104004079B (zh) * | 2014-06-17 | 2016-08-24 | 黄香利 | 一种紫色淮山药粘液蛋白的提取方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101317622A (zh) * | 2008-03-25 | 2008-12-10 | 江苏大学 | 一种山药糖蛋白产品及其超声辅助提取的方法 |
CN101575367A (zh) * | 2009-05-26 | 2009-11-11 | 上海应用技术学院 | 一种山药糖蛋白及其制备方法 |
-
2010
- 2010-05-13 CN CN 201010171533 patent/CN101890152B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101317622A (zh) * | 2008-03-25 | 2008-12-10 | 江苏大学 | 一种山药糖蛋白产品及其超声辅助提取的方法 |
CN101575367A (zh) * | 2009-05-26 | 2009-11-11 | 上海应用技术学院 | 一种山药糖蛋白及其制备方法 |
Non-Patent Citations (3)
Title |
---|
Kazunori Hironaka et al..Chemical Composition of Mucilage of Chinese Yam.《Nippon Shokuhin Kogyo Gakkaishi》.1990,第37卷(第1期),48-51. * |
郑素玲.山药对免疫机能低下小鼠耐缺氧能力的影响.《动物医学进展》.2010,第31卷(第2期),71-73. * |
郑素玲.山药改善老龄小鼠游泳耐力的研究.《安徽农业科学》.2009,第37卷(第35期),17526-17527. * |
Also Published As
Publication number | Publication date |
---|---|
CN101890152A (zh) | 2010-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101342317A (zh) | 一种治疗肺结核的药物组合物及其制备方法 | |
CN104623201B (zh) | 一种保肝排毒降脂降糖药物及其应用 | |
CN101890152B (zh) | 山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 | |
KR20160064966A (ko) | 화학요법제 보조에 사용하는 의약 조성물 및 그 용도 | |
CN101822818B (zh) | 山药多糖和山药蛋白质组合物及其用途 | |
CN103191214B (zh) | 一种解酒护肝制剂 | |
CN112971151A (zh) | 一种具有提高免疫力的人参核桃肽组合物及其制备方法 | |
CN101875648B (zh) | 一种从药用植物中提取纯化球松素的方法及其药物制剂与应用 | |
CN101933963A (zh) | 一种治疗头痛的鼻用原位凝胶剂 | |
CN101559166B (zh) | 一种麦冬提取物及其制备方法与降糖应用 | |
CN103948021A (zh) | 一种滁菊明目保健颗粒剂及其生产方法 | |
CN102631492B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN102078600A (zh) | 抗癌复方灵芝组合物、其用途和包含其的药物组合物 | |
CN104622912A (zh) | 一种无美洲大蠊异味的药物组合物 | |
CN113332314B (zh) | 一种牡蛎壳肉酶解物及其在制备治疗抑郁症的药物中的应用 | |
CN101015680B (zh) | F-苷肽在制备治疗肿瘤的药物中的应用 | |
CN114470147B (zh) | 沙棘籽粕蛋白肽在制备解酒产品中的应用 | |
CN102631506B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN102631486B (zh) | 一种保健组合物 | |
CN1611249A (zh) | 一种抗衰延年长寿丹 | |
CN102631487B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN102949681A (zh) | 一种预防或治疗感冒的组合物及其制备方法 | |
CN101019911B (zh) | 一种具有增强抗疲劳和调节免疫作用的中药组合物 | |
CN111700979A (zh) | 一种戒毒中药组合物及其应用 | |
CN102631489B (zh) | 提高免疫力、抗疲劳的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: KASHI AIWEIMATE UYGUR PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: MAMUTE DUOLIKUN Effective date: 20140605 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 830002 URUMQI, XINJIANG UYGUR AUTONOMOUS REGION TO: 844000 KASHGAR, XINJIANG UYGUR AUTONOMOUS REGION |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140605 Address after: 844000, Yingbin Road, the Xinjiang Uygur Autonomous Region, Kashi, No. 288 Patentee after: Kashi alamart Uygur Pharmaceutical Co.,Ltd. Address before: 830002 No. 496 Xinhua South Road, the Xinjiang Uygur Autonomous Region, Urumqi Patentee before: Duolikun.Mamute |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121205 Termination date: 20190513 |
|
RR01 | Reinstatement of patent right | ||
RR01 | Reinstatement of patent right |
Former decision: termination of patent right due to unpaid annual fee Former decision publication date: 20200501 |
|
RR01 | Reinstatement of patent right | ||
RR01 | Reinstatement of patent right |
Former decision: Termination of patent right without annual fee Former decision publication date: 20200501 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121205 |